BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 33098766)

  • 1. A Hyper-IgM Syndrome Mutation in Activation-Induced Cytidine Deaminase Disrupts G-Quadruplex Binding and Genome-wide Chromatin Localization.
    Yewdell WT; Kim Y; Chowdhury P; Lau CM; Smolkin RM; Belcheva KT; Fernandez KC; Cols M; Yen WF; Vaidyanathan B; Angeletti D; McDermott AB; Yewdell JW; Sun JC; Chaudhuri J
    Immunity; 2020 Nov; 53(5):952-970.e11. PubMed ID: 33098766
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel mouse model for the hyper-IgM syndrome: a spontaneous activation-induced cytidine deaminase mutation leading to complete loss of Ig class switching and reduced somatic hypermutation.
    Dahlberg CI; He M; Visnes T; Torres ML; Cortizas EM; Verdun RE; Westerberg LS; Severinson E; Ström L
    J Immunol; 2014 Nov; 193(9):4732-8. PubMed ID: 25252954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of aicda expression and AID activity: relevance to somatic hypermutation and class switch DNA recombination.
    Xu Z; Pone EJ; Al-Qahtani A; Park SR; Zan H; Casali P
    Crit Rev Immunol; 2007; 27(4):367-97. PubMed ID: 18197815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel activation-induced cytidine deaminase (AID) mutation in Brazilian patients with hyper-IgM type 2 syndrome.
    Caratão N; Cortesão CS; Reis PH; Freitas RF; Jacob CM; Pastorino AC; Carneiro-Sampaio M; Barreto VM
    Clin Immunol; 2013 Aug; 148(2):279-86. PubMed ID: 23803409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Novel AICDA Splice-Site Mutation in Two Siblings with HIGM2 Permits Somatic Hypermutation but Abrogates Mutational Targeting.
    Dirks J; Haase G; Cantaert T; Frey L; Klaas M; Rickert CH; Girschick H; Meffre E; Morbach H
    J Clin Immunol; 2022 May; 42(4):771-782. PubMed ID: 35246784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation induced cytidine deaminase mutant (AID-His130Pro) from Hyper IgM 2 patient retained mutagenic activity on SHM artificial substrate.
    Ouadani H; Ben-Mustapha I; Ben-Ali M; Larguèche B; Jovanic T; Garcia S; Arcangioli B; Elloumi-Zghal H; Fathallah D; Hachicha M; Masmoudi H; Rougeon F; Barbouche MR
    Mol Immunol; 2016 Nov; 79():77-82. PubMed ID: 27716525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Novel Heterozygous Variant in AICDA Impairs Ig Class Switching and Somatic Hypermutation in Human B Cells and is Associated with Autosomal Dominant HIGM2 Syndrome.
    Mina ED; Jackson KJL; Crawford AJI; Faulks ML; Pathmanandavel K; Acquarola N; O'Sullivan M; Kerre T; Naesens L; Claes K; Goodnow CC; Haerynck F; Kracker S; Meyts I; D'Orsogna LJ; Ma CS; Tangye SG
    J Clin Immunol; 2024 Feb; 44(3):66. PubMed ID: 38363477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathophysiology of B-cell intrinsic immunoglobulin class switch recombination deficiencies.
    Durandy A; Taubenheim N; Peron S; Fischer A
    Adv Immunol; 2007; 94():275-306. PubMed ID: 17560278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation-induced cytidine deaminase expression and activity in the absence of germinal centers: insights into hyper-IgM syndrome.
    Kuraoka M; Liao D; Yang K; Allgood SD; Levesque MC; Kelsoe G; Ueda Y
    J Immunol; 2009 Sep; 183(5):3237-48. PubMed ID: 19667096
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Depletion of recombination-specific cofactors by the C-terminal mutant of the activation-induced cytidine deaminase causes the dominant negative effect on class switch recombination.
    Al Ismail A; Husain A; Kobayashi M; Honjo T; Begum NA
    Int Immunol; 2017 Dec; 29(11):525-537. PubMed ID: 29136157
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HoxC4 binds to the promoter of the cytidine deaminase AID gene to induce AID expression, class-switch DNA recombination and somatic hypermutation.
    Park SR; Zan H; Pal Z; Zhang J; Al-Qahtani A; Pone EJ; Xu Z; Mai T; Casali P
    Nat Immunol; 2009 May; 10(5):540-50. PubMed ID: 19363484
    [TBL] [Abstract][Full Text] [Related]  

  • 12. AID expression during B-cell development: searching for answers.
    Kuraoka M; McWilliams L; Kelsoe G
    Immunol Res; 2011 Apr; 49(1-3):3-13. PubMed ID: 21136202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PTEN-Regulated AID Transcription in Germinal Center B Cells Is Essential for the Class-Switch Recombination and IgG Antibody Responses.
    Wang J; Liu S; Hou B; Yang M; Dong Z; Qi H; Liu W
    Front Immunol; 2018; 9():371. PubMed ID: 29541074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. AID and TET2 co-operation modulates FANCA expression by active demethylation in diffuse large B cell lymphoma.
    Jiao J; Jin Y; Zheng M; Zhang H; Yuan M; Lv Z; Odhiambo W; Yu X; Zhang P; Li C; Ma Y; Ji Y
    Clin Exp Immunol; 2019 Feb; 195(2):190-201. PubMed ID: 30357811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Negative regulation of activation-induced cytidine deaminase in B cells.
    Muto T; Okazaki IM; Yamada S; Tanaka Y; Kinoshita K; Muramatsu M; Nagaoka H; Honjo T
    Proc Natl Acad Sci U S A; 2006 Feb; 103(8):2752-7. PubMed ID: 16477013
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Independent Roles of Switching and Hypermutation in the Development and Persistence of B Lymphocyte Memory.
    Gitlin AD; von Boehmer L; Gazumyan A; Shulman Z; Oliveira TY; Nussenzweig MC
    Immunity; 2016 Apr; 44(4):769-81. PubMed ID: 26944202
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation-induced cytidine deaminase targets SUV4-20-mediated histone H4K20 trimethylation to class-switch recombination sites.
    Rodríguez-Cortez VC; Martínez-Redondo P; Català-Moll F; Rodríguez-Ubreva J; Garcia-Gomez A; Poorani-Subramani G; Ciudad L; Hernando H; Pérez-García A; Company C; Urquiza JM; Ramiro AR; Di Noia JM; Vaquero A; Ballestar E
    Sci Rep; 2017 Aug; 7(1):7594. PubMed ID: 28790320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation-induced cytidine deaminase: structure-function relationship as based on the study of mutants.
    Durandy A; Peron S; Taubenheim N; Fischer A
    Hum Mutat; 2006 Dec; 27(12):1185-91. PubMed ID: 16964591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyper IgM Syndrome Type 2 Presenting as Intestinal Lymphoid Polyposis Without Recurrent Infection.
    de la Varga-Martínez R; Vilches-Moreno M; Viejo-Almanzor A; Pérez-Requena J; Rodríguez C; Mora-López F
    J Investig Allergol Clin Immunol; 2020; 30(5):362-364. PubMed ID: 32694097
    [No Abstract]   [Full Text] [Related]  

  • 20. Phosphorylation promotes activation-induced cytidine deaminase activity at the Myc oncogene.
    Mu Y; Zelazowska MA; McBride KM
    J Exp Med; 2017 Dec; 214(12):3543-3552. PubMed ID: 29122947
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.